Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion

Stock Information for Cannara Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cannara Biotech Inc.

Cannara Appoints Nicholas Fozard as Chief Financial Officer
Cannara Establishes Automatic Share Purchase Plan
Cannara Announces Normal Course Issuer Bid
Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand(TM) Live Rosin Infusion Technology
Cannara Completes Acquisition of Medican Organic Inc.
Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.